MedTrace Logo

Long-term Impact of Infection With Novel Coronavirus (COVID-19)

NCT04362150 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2025-06-12

No results posted yet for this study

Summary

LIINC is a study of volunteers who were previously infected with SARS-CoV-2 (also known as novel coronavirus or COVID-19) who have recovered from acute infection. The study is designed to provide a specimen bank of samples with carefully characterized clinical data. LIINC specimens will be used to examine multiple questions involving the virologic, immunologic, and host factors involved in COVID-19, with a focus on understanding variability in the long-term immune response between individuals.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Steven Deeks, MD · University of California, San Francisco

  • Michael J Peluso, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-21
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04362150 on ClinicalTrials.gov